期刊
CANCER MICROENVIRONMENT
卷 5, 期 1, 页码 45-57出版社
SPRINGER
DOI: 10.1007/s12307-011-0080-9
关键词
Epithelial to mesenchymal transition; Cancer; Fibrosis; Microenvironment; Transforming growth factor-beta 1; Tumour necrosis factor alpha
类别
资金
- Medical Research Council UK [G0700861]
- Marie Curie fellowship award
- GlaxoSmithKline clinical fellowship award
- FLEECE Senior Lectureship
- Wellcome Trust [Vv-F086755MA]
- MRC [G0700861] Funding Source: UKRI
Epithelial to mesenchymal transition (EMT) is a process by which an epithelial cell alters its phenotype to that of a mesenchymal cell and plays a critical role in embryonic development, tumour invasion and metastasis and tissue fibrosis. Transforming growth factor-beta 1 (TGF beta 1) continues to be regarded as the key growth factor involved in driving EMT however recently tumour necrosis factor a (TNF alpha) has been demonstrated to accentuate TGF beta 1 driven EMT. In this study we investigate how various signalling pathways contribute to this accentuated effect. A549 cells were treated with TGF-beta 1 (10 ng/ml), TNFa (20 ngiml) or a combination of both for 72 h and EMT assessed. The effect of selective inhibition of the SMAD, MAPK and NF-kappa B pathways on EMT was assessed. A549 cells treated with TGF-beta 1 downregulate the expression of epithelial markers, increase the expression of mesenchymal markers, secrete matrix-metalloproteinases and become invasive. Significantly, TGF-beta 1 driven EMT is accentuated by co-treatment with TNFa. SMAD 3 inhibition attenuated TGF-beta 1 driven EMT but has no effect on the accentuation effect of TNFa. However, inhibiting IKK(3 blocked both TGF-beta 1 driven EMT and the accentuating action of TNF alpha. Inhibiting p38 and ERK signalling had no effect on EMT. TNFa accentuates TGF-beta 1 driven EMT in A549 cells via a SMAD 2/3 independent mechanism involving the NF-kappa B pathway independent of p38 and ERK 1/2 activation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据